X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2499) 2499
Book Review (417) 417
Publication (232) 232
Book Chapter (17) 17
Conference Proceeding (3) 3
Magazine Article (2) 2
Dissertation (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2159) 2159
humans (1446) 1446
animals (1124) 1124
male (729) 729
butyrate (562) 562
butyrates - pharmacology (557) 557
butyrates - therapeutic use (543) 543
sodium-butyrate (502) 502
female (500) 500
mice (455) 455
rats (360) 360
pharmacology & pharmacy (340) 340
apoptosis (314) 314
chain fatty-acids (311) 311
sodium butyrate (297) 297
esters (285) 285
adult (275) 275
histone deacetylase inhibitors (275) 275
oncology (269) 269
cancer (263) 263
expression (261) 261
microbiota (247) 247
middle aged (236) 236
fatty acids (223) 223
gene expression (219) 219
biochemistry & molecular biology (214) 214
analysis (209) 209
inflammation (201) 201
proteins (196) 196
research (195) 195
histone deacetylase (179) 179
cell biology (178) 178
acetylation (177) 177
gene-expression (173) 173
butyrates - metabolism (172) 172
cell line, tumor (169) 169
metabolism (167) 167
physiological aspects (166) 166
abridged index medicus (164) 164
diet (160) 160
dose-response relationship, drug (156) 156
multidisciplinary sciences (156) 156
disease models, animal (155) 155
article (154) 154
apoptosis - drug effects (151) 151
bacteria (151) 151
differentiation (151) 151
neurosciences (151) 151
gastroenterology & hepatology (150) 150
gut microbiota (150) 150
cells (146) 146
histone deacetylase inhibitors - pharmacology (146) 146
biotechnology & applied microbiology (140) 140
health aspects (139) 139
medicine (139) 139
aged (138) 138
rodents (135) 135
butyrates - administration & dosage (134) 134
nutrition & dietetics (128) 128
research article (127) 127
cells, cultured (122) 122
microbiology (122) 122
butyric acid (121) 121
activation (118) 118
histones - metabolism (116) 116
metabolites (116) 116
sodium (116) 116
immunology (114) 114
care and treatment (112) 112
fermentation (112) 112
intestine (112) 112
anticholesteremic agents - therapeutic use (111) 111
colon (111) 111
dietary fiber (111) 111
in-vitro (111) 111
probiotics (111) 111
cell line (109) 109
rats, sprague-dawley (106) 106
enzyme inhibitors - pharmacology (105) 105
mice, inbred c57bl (104) 104
cell differentiation - drug effects (103) 103
science (103) 103
histone deacetylase inhibitor (101) 101
time factors (101) 101
valproic acid (101) 101
colorectal cancer (100) 100
hematology (98) 98
disease (97) 97
growth (97) 97
cell proliferation - drug effects (95) 95
butyrate-producing bacteria (94) 94
medicine, research & experimental (94) 94
butyric acid - pharmacology (92) 92
antineoplastic agents - pharmacology (90) 90
biotechnology (90) 90
histone deacetylases - metabolism (90) 90
tumor cells, cultured (90) 90
oxidative stress (89) 89
in-vivo (88) 88
biology (87) 87
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2358) 2358
German (38) 38
French (35) 35
Italian (27) 27
Russian (15) 15
Japanese (10) 10
Polish (6) 6
Chinese (5) 5
Czech (4) 4
Portuguese (3) 3
Hungarian (2) 2
Norwegian (2) 2
Dutch (1) 1
Korean (1) 1
Romanian (1) 1
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Movement Disorders, ISSN 0885-3185, 05/2017, Volume 32, Issue 5, pp. 739 - 749
Background: There is mounting evidence for a connection between the gut and Parkinson's disease (PD). Dysbiosis of gut microbiota could explain several... 
confounding | Parkinson's disease | gut microbiome | functional pathways | medications | COMMUNITIES | CLINICAL NEUROLOGY | TAXONOMY | RIBOSOMAL-RNA SEQUENCES | MICROGLIA | CHAIN FATTY-ACIDS | SODIUM-BUTYRATE | ASSIGNMENT | DIVERSITY | ASSOCIATION | MANIFESTATIONS | United States - epidemiology | Vegetables | Age Factors | Humans | Lactobacillaceae - genetics | Male | Parkinson Disease - drug therapy | Dysbiosis - microbiology | Case-Control Studies | Antiparkinson Agents - therapeutic use | Carbidopa - therapeutic use | Parkinson Disease - epidemiology | Female | Verrucomicrobia - genetics | Cholinergic Antagonists - therapeutic use | Fruit | Pasteurellaceae - genetics | Levodopa - therapeutic use | Bifidobacterium - genetics | Risk Factors | Catechol O-Methyltransferase Inhibitors - therapeutic use | Gastrointestinal Microbiome - genetics | Confounding Factors (Epidemiology) | Parkinson Disease - microbiology | Diet | Dysbiosis - epidemiology | Sex Factors | RNA, Ribosomal, 16S - genetics | Drug Combinations | Physiological aspects | Microbiota (Symbiotic organisms) | RNA | Xenobiotics | Analysis | Antiparkinsonian agents | Dysbacteriosis | rRNA 16S | Demography | Neurodegenerative diseases | Digestive system | Methyltransferase | Parkinsons disease | Abundance | Catechol | Catechol O-methyltransferase | Plants | Levodopa | Digestive tract | Movement disorders | Deoxyribonucleic acid--DNA | DNA sequencing | Index Medicus
Journal Article
Atherosclerosis, ISSN 0021-9150, 2017, Volume 261, pp. 144 - 152
Journal Article
Molecular Therapy, ISSN 1525-0016, 09/2008, Volume 16, Issue 9, pp. 1546 - 1555
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 12/2013, Volume 123, Issue 12, pp. 5052 - 5060
Children conceived by assisted reproductive technologies (ART) display a level of vascular dysfunction similar to that seen in children of mothers with... 
PATERNAL METHYLATION | PULMONARY | MEDICINE, RESEARCH & EXPERIMENTAL | EPIGENETIC INHERITANCE | DNA METHYLATION | NITRIC-OXIDE SYNTHASE | INSULIN-RESISTANCE | MOUSE | DISEASE | IMPRINTED GENE | ASSISTED REPRODUCTIVE TECHNOLOGIES | Butyrates - pharmacology | Nitric Oxide Synthase Type III - biosynthesis | Male | Vascular Resistance - physiology | Hypertension - etiology | DNA Methylation | Cardiovascular Abnormalities - etiology | Gene Expression Regulation, Developmental | Butyrates - therapeutic use | Fertilization in Vitro - methods | Female | Nitric Oxide Synthase Type III - physiology | Vasodilation - physiology | Aorta - enzymology | Ovulation Induction - adverse effects | Endothelium, Vascular - embryology | Fertilization in Vitro - adverse effects | Promoter Regions, Genetic | Disease Susceptibility | Down-Regulation | Endothelium, Vascular - physiopathology | Cardiovascular Abnormalities - embryology | Longevity | Nitric Oxide Synthase Type III - genetics | Hypertension - physiopathology | Gene Expression Regulation, Enzymologic | Diet, Atherogenic | Animals | Hypertension - embryology | Histone Deacetylase Inhibitors - pharmacology | Histone Deacetylase Inhibitors - therapeutic use | Mice | Nitric Oxide - metabolism | Infants (Newborn) | Blood circulation disorders | Research | Risk factors | Reproductive technology | Diseases | Studies | Blood pressure | Rodents | Metabolic disorders | Index Medicus | Abridged Index Medicus
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 2, pp. 398 - 414.e6
The most common question asked by patients with inflammatory bowel disease (IBD) is, “Doctor, what should I eat?” Findings from epidemiology studies have... 
Gastroenterology and Hepatology | Inflammatory Bowel Disease | Diet | Short-Chain Fatty Acids | Microbiome | VITAMIN-D-RECEPTOR | MICROVASCULAR ENDOTHELIAL-CELLS | FUNCTIONAL GASTROINTESTINAL SYMPTOMS | BUTYRATE-PRODUCING BACTERIA | HEALTHY 1ST-DEGREE RELATIVES | ARYL-HYDROCARBON RECEPTOR | POLYUNSATURATED FATTY-ACIDS | SODIUM-INDUCED COLITIS | GASTROENTEROLOGY & HEPATOLOGY | ALPHA-LINOLENIC ACID | SULFATE-REDUCING BACTERIA | Crohn Disease - epidemiology | Vegetables | Curcumin - therapeutic use | Fruit | Diet - statistics & numerical data | Humans | Risk Factors | Gastrointestinal Microbiome | Crohn Disease - diet therapy | Fermentation | Inflammatory Bowel Diseases - diet therapy | Inflammation - diet therapy | Inflammatory Bowel Diseases - epidemiology | Vitamin D Deficiency - epidemiology | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Dysbiosis - epidemiology | Fatty Acids, Volatile | Dietary Fats | Dietary Fiber | Emulsifying Agents | Diet Therapy | Dysbiosis - diet therapy | Fatty Acids, Omega-6 - therapeutic use | Dietary Supplements | Medical colleges | Care and treatment | Dietary supplements | Calcifediol | Esters | Fatty acids | Epidemiology | Polyols | Risk factors | Monosaccharides | Vitamin D | Analysis | Gastrointestinal diseases | Alfacalcidol | Colitis | Kidney diseases | Sugars | Medical research | Triglycerides | Sulfates | Hydrogen sulfide | Unsaturated fatty acids | Medicine, Experimental | Ulcerative colitis | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 06/2007, Volume 321, Issue 3, pp. 892 - 901
Journal Article
Circulation, ISSN 0009-7322, 07/2001, Volume 104, Issue 4, pp. 387 - 392
Journal Article
Blood, ISSN 0006-4971, 03/2007, Volume 109, Issue 6, pp. 2571 - 2578
Journal Article
FASEB Journal, ISSN 0892-6638, 06/2013, Volume 27, Issue 6, pp. 2256 - 2269
As a strategy to treat Duchenne muscular dystrophy, we used arginine butyrate, which combines two pharmacological activities: nitric oxide pathway activation,... 
Mdx | Histone deacetylase | NO | DMD | Pharmacology | Treatment | mdx | treatment | LOCALIZATION | REGENERATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | DEFICIENT SKELETAL-MUSCLE | SATELLITE CELLS | histone deacetylase | MDX MICE | CELL BIOLOGY | GLOBIN GENE-EXPRESSION | BETA-HEMOGLOBINOPATHIES | UTROPHIN TRANSGENE | pharmacology | BIOLOGY | NITRIC-OXIDE | DYSTROPHINOPATHIES | Muscular Dystrophy, Animal - drug therapy | Muscular Dystrophy, Animal - physiopathology | Humans | Utrophin - genetics | Male | Muscle Fibers, Skeletal - drug effects | Muscle Fibers, Skeletal - metabolism | Muscular Dystrophy, Animal - pathology | Arginine - analogs & derivatives | Arginine - administration & dosage | Muscular Dystrophy, Duchenne - physiopathology | Butyrates - therapeutic use | Mice, Inbred mdx | Butyrates - administration & dosage | Animals, Newborn | Muscular Dystrophy, Duchenne - drug therapy | Mice, Inbred C57BL | Cells, Cultured | Muscular Dystrophy, Duchenne - pathology | Drug Synergism | Up-Regulation - drug effects | Animals | Histone Deacetylase Inhibitors - therapeutic use | Mice | Arginine - therapeutic use | Index Medicus | Up-Regulation | Neurons and Cognition | Life Sciences | Muscle Fibers, Skeletal | Arginine | Butyrates | Utrophin | Muscular Dystrophy, Animal | Histone Deacetylase Inhibitors | Muscular Dystrophy, Duchenne
Journal Article